HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanistic insights into cell-free hemoglobin-induced injury during septic shock.

Abstract
Cell-free hemoglobin (CFH) levels are elevated in septic shock and are higher in nonsurvivors. Whether CFH is only a marker of sepsis severity or is involved in pathogenesis is unknown. This study aimed to investigate whether CFH worsens sepsis-associated injuries and to determine potential mechanisms of harm. Fifty-one, 10-12 kg purpose-bred beagles were randomized to receive Staphylococcus aureus intrapulmonary challenges or saline followed by CFH infusions (oxyhemoglobin >80%) or placebo. Animals received antibiotics and intensive care support for 96 h. CFH significantly increased mean pulmonary arterial pressures and right ventricular afterload in both septic and nonseptic animals, effects that were significantly greater in nonsurvivors. These findings are consistent with CFH-associated nitric oxide (NO) scavenging and were associated with significantly depressed cardiac function, and worsened shock, lactate levels, metabolic acidosis, and multiorgan failure. In septic animals only, CFH administration significantly increased mean alveolar-arterial oxygenation gradients, also to a significantly greater degree in nonsurvivors. CFH-associated iron levels were significantly suppressed in infected animals, suggesting that bacterial iron uptake worsened pneumonia. Notably, cytokine levels were similar in survivors and nonsurvivors and were not predictive of outcome. In the absence and presence of infection, CFH infusions resulted in pulmonary hypertension, cardiogenic shock, and multiorgan failure, likely through NO scavenging. In the presence of infection alone, CFH infusions worsened oxygen exchange and lung injury, presumably by supplying iron that promoted bacterial growth. CFH elevation, a known consequence of clinical septic shock, adversely impacts sepsis outcomes through more than one mechanism, and is a biologically plausible, nonantibiotic, noncytokine target for therapeutic intervention.NEW & NOTEWORTHY Cell-free hemoglobin (CFH) elevations are a known consequence of clinical sepsis. Using a two-by-two factorial design and extensive physiological and biochemical evidence, we found a direct mechanism of injury related to nitric oxide scavenging leading to pulmonary hypertension increasing right heart afterload, depressed cardiac function, worsening circulatory failure, and death, as well as an indirect mechanism related to iron toxicity. These discoveries alter conventional thinking about septic shock pathogenesis and provide novel therapeutic approaches.
AuthorsJeffrey Wang, Willard N Applefeld, Junfeng Sun, Steve B Solomon, Jing Feng, Zoe G Couse, Thomas F Risoleo, Robert L Danner, Jesús Tejero, Juan Lertora, Elmira Alipour, Swati Basu, Vandana Sachdev, Daniel B Kim-Shapiro, Mark T Gladwin, Harvey G Klein, Charles Natanson
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 320 Issue 6 Pg. H2385-H2400 (06 01 2021) ISSN: 1522-1539 [Electronic] United States
PMID33989079 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins
  • Nitric Oxide
  • Lactic Acid
  • Iron
Topics
  • Acidosis (metabolism, physiopathology)
  • Acute Lung Injury (metabolism, physiopathology)
  • Animals
  • Blood Pressure (drug effects, physiology)
  • Dogs
  • Heart Ventricles (drug effects, physiopathology)
  • Hemoglobins (metabolism, pharmacology)
  • Iron (metabolism)
  • Lactic Acid (metabolism)
  • Multiple Organ Failure (metabolism, physiopathology)
  • Nitric Oxide (metabolism)
  • Pneumonia (metabolism, physiopathology)
  • Pulmonary Artery (physiopathology)
  • Pulmonary Gas Exchange
  • Random Allocation
  • Shock, Septic (metabolism, physiopathology)
  • Staphylococcal Infections (metabolism)
  • Staphylococcus aureus (growth & development)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: